The Patent Finder

Vanquish Oncology, Inc.

Also on record
Records under this name other than patents Vanquish Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Vanquish Oncology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,399,035Procaspase 3 Activation by Combination Therapy
In force
 · High confidence
In forceHigh confidence
US 9,421,202Procaspase Combination Therapy for Glioblastoma
In force
 · High confidence
In forceHigh confidence
US 10,085,977Procaspase 3 Activation by Combination Therapy
In force
 · Medium confidence
In forceMedium confidence
US 10,085,978Procaspase Combination Therapy for Glioblastoma
In force
 · High confidence
In forceHigh confidence
US 10,874,666Procaspase Combination Therapy for Glioblastoma
In force
 · High confidence
In forceHigh confidence
US 10,888,560Procaspase 3 Activation by Combination Therapy
In force
 · Low confidence
In forceLow confidence
US 11,844,798Procaspase Combination Therapy for Glioblastoma
In force
 · High confidence
In forceHigh confidence
US 12,433,885Procaspase Combination Therapy for Glioblastoma
In force
 · High confidence
In forceHigh confidence
US 9,592,229Potent Anticancer Activity via Dual Compound Activation
In force
 · High confidence
In forceHigh confidence
US 11,833,147Procaspase 3 Activation by Combination Therapy
In force
 · Medium confidence
In forceMedium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited